UTI Medium to Long Term Fund
Medium to Long Duration · Direct Growth Very High Risk
₹82.5853
NAV on 28-Oct-2026
Showing the Direct plan. The Regular plan you picked has the same portfolio but a higher expense ratio, so its NAV and returns are lower.
Fund size (AUM)
₹303 Cr
Expense ratio
1.32%
Since inception (CAGR)
+6.59%
Minimum SIP · lump sum
₹500 · ₹500
Returns
absolute up to 1Y, annualised beyond| 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|---|
| This fund | -0.54% | -0.93% | +1.38% | +2.20% | +6.18% | +6.73% | +5.21% |
| Category average | — | -0.85% | +1.39% | +2.49% | +6.54% | +5.73% | — |
About
| Fund house | UTI Mutual Fund |
| Fund managers | Amandeep Chopra |
| Benchmark | CRISIL Medium to Long Duration Debt A-III Index |
| Launched | 01-Jan-2013 |
| ISIN | INF789F01SQ6 |
| Exit load | — |
Risk
| Standard deviation | 2.54 |
| Sharpe ratio | 0.21 |
| Sortino ratio | 0.31 |
| Alpha | — |
| Beta | — |
Top holdings
29 in total| Holding | Sector | Value | % of fund |
|---|---|---|---|
| GOVERNMENT OF INDIA 35840 GOI 15AP65 6.9 FV RS 100 | Entities | ₹27 Cr | 8.87% |
| SUMMIT DIGITEL INFRASTRUCTURE PRIVATE LIMITED 7.40 NCD 28SP28 FVRS10LAC | Technology | ₹25 Cr | 8.18% |
| BAJAJ HOUSING FINANCE LIMITED 7.02 NCD 26MY28 FVRS1LAC | Financial | ₹25 Cr | 8.10% |
| 7.08% ANDHRA PRADESH SDL 26-MAR-37 | Financial | ₹24 Cr | 7.75% |
| SIDDHIVINAYAK SECURITISATION TRUST SD TRUST PTC 15SEPT25 | Unspecified | ₹19 Cr | 6.30% |
| JTPM METAL TRADERS LIMITED NCD 30AP30 FVRS1LAC | Materials | ₹17 Cr | 5.69% |
| PIRAMAL FINANCE LIMITED 9.15 NCD 17JU27 FVRS1LAC | Financial | ₹15 Cr | 4.96% |
| MUTHOOT FINANCE LIMITED RR NCD 04SP29 FVRS1LAC | Financial | ₹15 Cr | 4.95% |
| ADITYA BIRLA RENEWABLES LIMITED 8.6 NCD 24SP27 FVRS1LAC | Energy & Utilities | ₹15 Cr | 4.94% |
| TORRENT PHARMACEUTICALS LTD SR 2 7.60 NCD 19JN29 FVRS1LAC | Healthcare | ₹15 Cr | 4.89% |
| GOVERNMENT OF INDIA 36320 GOI 18AG55 7.24 FV RS 100 | Entities | ₹14 Cr | 4.69% |
| India Universal Trust AL1 Sec. Debt 8.20 20/09/2030 | Unspecified | ₹13 Cr | 4.14% |
| STATE DEVELOPMENT LOAN 37318 RAJ 30MR41 7.99 FV RS 100 | Unspecified | ₹10 Cr | 3.32% |
| MANKIND PHARMA LIMITED SR 3 7.97 NCD 16NV27 FVRS1LAC | Healthcare | ₹10 Cr | 3.30% |
| Net Current Assets | Unspecified | ₹10 Cr | 3.23% |
| STATE DEVELOPMENT LOAN 37247 TN 18MR38 7.57 FV RS 100 | Unspecified | ₹10 Cr | 3.22% |
| STATE DEVELOPMENT LOAN 37106 WB 18FB44 7.74 FV RS 100 | Unspecified | ₹9 Cr | 3.05% |
| POONAWALLA FINCORP LIMITED 7.6841 SR I1 NCD 20MR28 FVRS1LAC | Financial | ₹7 Cr | 2.29% |
| 7.74% Maharashtra SDL 2033 | Unspecified | ₹5 Cr | 1.66% |
| STATE DEVELOPMENT LOAN 32797 RAJ 29MR33 7.78 FV RS 100 | Unspecified | ₹5 Cr | 1.65% |
Fetched 29 Oct, 17:38 IST. Past returns don't predict future returns. Source: Indian Stock API.